SciELO - Scientific Electronic Library Online

 
vol.33 número3La Farmacia Hospitalaria ante situaciones de emergencia nuclearRevisión del tratamiento no farmacológico del dolor en neonatos con sacarosa oral índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la OFIL

versão On-line ISSN 1699-714Xversão impressa ISSN 1131-9429

Resumo

CONTE-VALDES, E et al. Study on the situational diagnosis of the National Drug Policy of Panama. Rev. OFIL·ILAPHAR [online]. 2023, vol.33, n.3, pp.300-305.  Epub 28-Fev-2024. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2023000300014.

Objective:

Collect and analyze information regarding the situation of the National Drug Policy of Panama in 2018-2019.

Methods:

It´s a descriptive study related to the situational diagnosis and fulfillment of the objectives and principles on which the National Drug Policy (PNM) is based according to its legal foundations. A survey was prepared based on the components, guidelines and strategies set out in the PNM related to the pharmaceutical sector, both public and private. From a list of email contacts, recipients related to the topic were chosen and the survey was applied to them through the Survey Monkey platform.

Results:

230 people answered where 65% were women, the age group that most participated was 51 to 55 years old, 54.3% were pharmacists. 84% of those interviewed answered that the National Drug Commission of Panama had been created. 90% indicated that there was a regulatory framework aimed at monitoring the quality of drugs. 78% reported that there is an exchange of information and early warnings with the use of drugs at the national level.

Conclusions:

This situational diagnosis was not aimed at examining, correcting or qualifying the efforts that could have been made for the development of the National Drug Policy, giving us the general conception that the respondents had about it, considering that this exercise was carried out in the years 2018-2019. It is up to the governing body to propose its own evaluation of the PNM.

Palavras-chave : Medicines Policy; access; rational use; quality.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )